Sastre, Diego E. http://orcid.org/0000-0003-2010-5398
Sultana, Nazneen
V. A. S. Navarro, Marcos
Huliciak, Maros http://orcid.org/0000-0002-9929-3522
Du, Jonathan
Cifuente, Javier O. http://orcid.org/0000-0001-5420-121X
Flowers, Maria http://orcid.org/0000-0002-1814-7049
Liu, Xu
Lollar, Pete
Trastoy, Beatriz http://orcid.org/0000-0002-2178-732X
Guerin, Marcelo E. http://orcid.org/0000-0001-9524-3184
Sundberg, Eric J. http://orcid.org/0000-0003-0478-3033
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM148075)
Article History
Received: 12 December 2023
Accepted: 15 May 2024
First Online: 15 June 2024
Competing interests
: Based on the development of an artificial lectin, BT1285i, with high specificity and high affinity for oligomannose <i>N</i>-glycans, D.E.S. and E.J.S. are inventors on a provisional patent application No. 63/538,956 filed with the Patent and Trademark Office by Emory University. All other authors declare they have no competing interests.